Richard Cornford

Richard Cornford is currently the Global Head of Early Commercial for CVRM, Cardiovascular, and NASH/Liver disease at AstraZeneca. Previously, they held several leadership positions at AstraZeneca, including Global Brand Head for Diabetes and Global Strategic Head for the CV, Renal & Metabolic Portfolio. Richard's experience also includes director roles at Bristol-Myers Squibb, where they managed various specialty care and metabolic business units and successfully led the launch of key diabetes products. They began their career in sales and marketing at GSK, progressing through various roles over a decade. Richard holds a BSc Hons in Physiology and Pharmacology from The University of Manchester and completed an Entrepreneurial Leadership Executive Programme at MIT.